VK
Vaibhav Kumar
U.S. Food and Drug Administration, The University of North Carolina at Chapel Hill, Tufts University
0000-0002-5594-9497
Employment
-
U.S. Food and Drug Administration Medical Officer2021 - Present
-
The University of North Carolina at Chapel Hill Fellow2018 - 2021
-
Tufts University Post-Doctoral Fellow2016 - 2018
-
Tufts Medical Center Resident2014 - 2016
-
Central Manchester University Hospitals NHS Foundation Trust Core Medical Training2011 - 2013
-
University Hospital of South Manchester NHS Foundation Trust Foundation Training2009 - 2011
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Challenges in Automating Extraction of Real-World Radiographic Images and Adverse Events: Lessons From the ICAREdata Initiative. Save
- Supplementary Table S1: FDA Benefit Risk Assessment and Summary from FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor Save
- FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer Save
- Association of Inferior Vena Cava Filter with Mortality and Intracranial Hemorrhage in Patients with Selected Cancers and Brain Metastasis Save
- Landscape Analysis of Generic Availability for Oncologic Drugs. Save
- Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report. Save
- FDA Approval Summary: Ripretinib for advanced gastrointestinal stromal tumor. Save
- Temporal Changes in Treatment Patterns for Rural and Urban Patients With Early-Stage Non-Small Cell Lung Cancer. Save
- Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 Infection. Save
- Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma. Save